Market Mastery

Our take on the current biotechnology and pharmaceutical landscape, current candidate trends, industry news and updates, state of funding in biopharma, and more.
Scientific image of blue and purple cells on a dark background.

Articles

124
select a category
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

BL.

Unveiling Biotech's Lucrative Investment Opportunities and Prolific Clinical Trials

Heading

June 21, 2023

In this article, we explore the specific therapeutic areas that have the highest return on VC investment in the biotech industry.

BL.

Navigating the Regulatory Landscape in Today's Biotech Industry: Is it Getting Harder to Get Drugs Approved?

Heading

June 21, 2023

This article explores the regulatory environment of today's biotech industry

BL.

The Strategic Decision: When to Hire a Quality Assurance Team to Ensure Successful Clinical Programs?

Heading

June 21, 2023

This article outlines key factors that biotech CEOs should consider when determining the right time to hire a QA team for effective oversight of their clinical trials.

BL.

Navigating Challenges in the CMC Function: The Impact of Regulation and Economic Conditions in the Biotech Industry

Heading

June 7, 2023

This article will explore the key challenges faced by the CMC function and the effects of economic conditions on their responsibilities.

BL.

The Decline of Venture Capital in Biotech: A Challenging Phase for the Industry

Heading

June 5, 2023

This article examines the factors behind this decline and explores projections for when the industry can anticipate the return of more VC investments.

BL.

Quiet Quitting: Separating the Symptom from the Cause

Heading

October 13, 2022

Quiet quitting. What began as a viral video has become one of the most talked about (and written about) topics this year.

Relationships that resource transformative therapeutics